• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

苯环己哌啶对大鼠回避电击任务中亮度辨别能力的破坏作用及其拮抗作用

Disruption of brightness discrimination in a shock avoidance task by phencyclidine and its antagonism in rats.

作者信息

Tang A H, Franklin S R

出版信息

J Pharmacol Exp Ther. 1983 Jun;225(3):503-8.

PMID:6864515
Abstract

Rats were trained to make a simultaneous brightness discrimination in order to avoid or escape foot shocks in an automated Y-maze. Brightness discrimination was completely disrupted by phencyclidine (PCP, 3 mg/kg), ketamine (30 mg/kg) and dexoxadrol (10 mg/kg). At these doses, there was increased locomotor activity between trials. The number of movement attempts to avoid shock during a trial were either unchanged or reduced. Several drugs with various clinical applications (chlorpromazine, haloperidol, diazepam, pentobarbital, d-amphetamine, propranolol, clonidine and prazosin) did not impair brightness discrimination in behavioral stimulant or depressant doses. The levoisomer of dexoxadrol, levoxadrol, was also inactive. Daily administration of PCP for 5 consecutive days produced progressive increases in locomotor stimulation with no tolerance to effects on brightness disruption. The disruption of brightness discrimination by PCP was not reversed by chlorpromazine, haloperidol, diazepam, propranolol or apomorphine at doses which reduced the locomotor stimulation by PCP. Both locomotor stimulation and discrimination disruption were blocked by prazosin and clonidine. A central adrenergic mechanism is implicated for some behavioral effects of PCP.

摘要

训练大鼠在自动 Y 迷宫中进行同时性亮度辨别,以避免或逃避足部电击。苯环己哌啶(PCP,3mg/kg)、氯胺酮(30mg/kg)和右吗拉胺(10mg/kg)完全破坏了亮度辨别。在这些剂量下,试验期间的自发活动增加。试验期间为避免电击而进行的运动尝试次数要么不变,要么减少。几种具有不同临床应用的药物(氯丙嗪、氟哌啶醇、地西泮、戊巴比妥、d-苯丙胺、普萘洛尔、可乐定和哌唑嗪)在行为兴奋或抑制剂量下均未损害亮度辨别。右吗拉胺的左旋异构体左吗拉胺也无活性。连续 5 天每日给予 PCP 会使自发活动逐渐增加,且对亮度辨别破坏作用无耐受性。氯丙嗪、氟哌啶醇、地西泮、普萘洛尔或阿扑吗啡在降低 PCP 引起的自发活动的剂量下,并不能逆转 PCP 对亮度辨别的破坏作用。哌唑嗪和可乐定可阻断自发活动和辨别破坏。PCP 的某些行为效应涉及中枢肾上腺素能机制。

相似文献

1
Disruption of brightness discrimination in a shock avoidance task by phencyclidine and its antagonism in rats.苯环己哌啶对大鼠回避电击任务中亮度辨别能力的破坏作用及其拮抗作用
J Pharmacol Exp Ther. 1983 Jun;225(3):503-8.
2
Acquisition of brightness discrimination in the rat is impaired by opiates with psychotomimetic properties.具有拟精神病特性的阿片类药物会损害大鼠的亮度辨别能力。
Pharmacol Biochem Behav. 1983 Jun;18(6):873-7. doi: 10.1016/s0091-3057(83)80008-2.
3
A comparison of the discriminable CNS effects of ketamine, phencyclidine and pentobarbital.氯胺酮、苯环己哌啶和戊巴比妥可辨别中枢神经系统效应的比较。
Arch Int Pharmacodyn Ther. 1975 Jun;215(2):180-9.
4
Place-aversion conditioned by phencyclidine in rats: development of tolerance and pharmacologic antagonism.苯环利定对大鼠的位置厌恶条件反射:耐受性的发展及药理学拮抗作用
Alcohol Drug Res. 1985;6(4):265-76.
5
Evaluation of antagonists of the discriminative stimulus and response rate effects of phencyclidine.苯环利定辨别刺激和反应率效应拮抗剂的评估。
J Pharmacol Exp Ther. 1988 Jan;244(1):34-40.
6
Effects of phencyclidine-type drugs in rats discriminating fentanyl from saline: pharmacological and behavioral characterization of intermediate levels of drug lever selection.苯环利定类药物对辨别芬太尼与生理盐水的大鼠的影响:药物杠杆选择中间水平的药理学和行为学特征
J Pharmacol Exp Ther. 1993 Feb;264(2):746-56.
7
Phencyclidine-like behavioral effects of 2-methyl-3,3-diphenyl-3-propanolamine (2-MDP).2-甲基-3,3-二苯基-3-丙醇胺(2-MDP)类似苯环己哌啶的行为效应
Pharmacol Biochem Behav. 1984 Feb;20(2):209-13. doi: 10.1016/0091-3057(84)90244-2.
8
Phencyclidine-like discriminative stimulus properties of the stereoisomers of dioxadrol.二氧卓醇立体异构体的苯环利定样辨别刺激特性
Subst Alcohol Actions Misuse. 1984;5(6):273-80.
9
Structure-activity relationship studies of phencyclidine derivatives in rats.大鼠中苯环己哌啶衍生物的构效关系研究。
J Pharmacol Exp Ther. 1984 Jan;228(1):147-53.
10
Clozapine but not haloperidol treatment reverses sub-chronic phencyclidine-induced disruption of conditional discrimination performance.氯氮平而非氟哌啶醇治疗可逆转亚慢性苯环利定诱导的条件性辨别行为破坏。
Behav Brain Res. 2006 Dec 15;175(2):271-7. doi: 10.1016/j.bbr.2006.08.028. Epub 2006 Oct 5.

引用本文的文献

1
Differential effects of glutamate N-methyl-D-aspartate receptor antagonists on risky choice as assessed in the risky decision task.谷氨酸 N-甲基-D-天冬氨酸受体拮抗剂在风险决策任务中评估的风险选择中的差异效应。
Psychopharmacology (Berl). 2021 Jan;238(1):133-148. doi: 10.1007/s00213-020-05664-z. Epub 2020 Sep 16.
2
Effects of N-methyl-D-aspartate receptor ligands on sensitivity to reinforcer magnitude and delayed reinforcement in a delay-discounting procedure.N-甲基-D-天冬氨酸受体配体对延迟折扣程序中强化物强度敏感性和延迟强化的影响。
Psychopharmacology (Berl). 2017 Feb;234(3):461-473. doi: 10.1007/s00213-016-4469-5. Epub 2016 Nov 11.
3
Glutamate, learning and dementia-selection of evidence.
谷氨酸、学习与痴呆——证据选择。
Amino Acids. 1994 Jun;7(2):147-63. doi: 10.1007/BF00814157.
4
Cognitive-disruptive effects of the psychotomimetic phencyclidine and attenuation by atypical antipsychotic medications in rats.拟精神病药物苯环利定对大鼠的认知干扰作用及非典型抗精神病药物的减弱作用。
Psychopharmacology (Berl). 2007 Sep;193(4):521-37. doi: 10.1007/s00213-007-0808-x. Epub 2007 May 12.
5
A low dose of the alpha2 agonist clonidine ameliorates the visual attention and spatial working memory deficits produced by phencyclidine administration to rats.低剂量的α2激动剂可乐定可改善给大鼠注射苯环利定所产生的视觉注意力和空间工作记忆缺陷。
Psychopharmacology (Berl). 2004 Aug;175(1):76-83. doi: 10.1007/s00213-004-1772-3. Epub 2004 Mar 6.
6
Effects of phencyclidine, SKF 10,047 and related psychotomimetic agents on N-methyl-D-aspartate receptor mediated synaptic responses in rat hippocampal slices.苯环利定、SKF 10047及相关拟精神病药物对大鼠海马脑片N-甲基-D-天冬氨酸受体介导的突触反应的影响。
Br J Pharmacol. 1987 Jul;91(3):547-56. doi: 10.1111/j.1476-5381.1987.tb11248.x.
7
Evidence for multiple opiate receptor involvement in different phencyclidine-induced unconditioned behaviors in rats.多种阿片受体参与大鼠不同苯环利定诱导的非条件性行为的证据。
Psychopharmacology (Berl). 1986;88(1):44-53. doi: 10.1007/BF00310511.